Healthcare Delivery

Inequalities in access to healthcare and medicines persist across the European Union, with increasing prices of medicines and a lack of transparency in the pharmaceutical sector being key drivers of this unequal access. This issue affects countries and people within the EU, yet the problem is even worse in other parts of the world, where out-of-pocket payments cause financial hardship to patients and their relatives, threatening universal health coverage and progress towards Sustainable Development Goals (SDGs). 

Lack of transparency in the pharmaceutical sector, in particular around research and development (R&D) costs makes it virtually impossible for national payers to come up with fair prices that reward their efforts while keeping medicines affordable. EPHA’s work contributes to equitable access to medicines and healthcare by bringing the voice of people to ensure balanced policy debates around fair pricing for medicines and a ‘fair return’ on public contributions to R&D, among other key topics.

Related Campaigns

European Alliance for Responsible R&D and Affordable Medicines

European Alliance for Responsible R&D and Affordable Medicines The Alliance strives for the creation of...

Access to Medicines Dialogues

EPHA #A2MDialogues A series of online, live, public dialogues putting the spotlight on actionable solutions...

Related publications

Latest Events

January 18, 2022

Transparency of (real) pharmaceutical costs

Transparency of (real) pharmaceutical costs Join the second event of the Zooming in on Solution...


Madda Magbity

Madda Magbity

Policy Manager

Get the EPHA Newsletter

The best of our activities, right in your inbox!

Get involved !

Get involved !

Sign up here to receive our updates on European health policy and invitations to our events.

Subscribe now

You have Successfully Subscribed!